IBDEI0EF ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6956,1,5,0)
 ;;=5^Hepatitis,Autoimmune
 ;;^UTILITY(U,$J,358.3,6956,2)
 ;;=^336610
 ;;^UTILITY(U,$J,358.3,6957,0)
 ;;=787.21^^55^574^21
 ;;^UTILITY(U,$J,358.3,6957,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6957,1,4,0)
 ;;=4^787.21
 ;;^UTILITY(U,$J,358.3,6957,1,5,0)
 ;;=5^Dysphagia,Oral Phase
 ;;^UTILITY(U,$J,358.3,6957,2)
 ;;=^335276
 ;;^UTILITY(U,$J,358.3,6958,0)
 ;;=787.22^^55^574^22
 ;;^UTILITY(U,$J,358.3,6958,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6958,1,4,0)
 ;;=4^787.22
 ;;^UTILITY(U,$J,358.3,6958,1,5,0)
 ;;=5^Dysphagia,Oropharyngeal
 ;;^UTILITY(U,$J,358.3,6958,2)
 ;;=^335277
 ;;^UTILITY(U,$J,358.3,6959,0)
 ;;=787.23^^55^574^23
 ;;^UTILITY(U,$J,358.3,6959,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6959,1,4,0)
 ;;=4^787.23
 ;;^UTILITY(U,$J,358.3,6959,1,5,0)
 ;;=5^Dysphagia,Pharyngeal
 ;;^UTILITY(U,$J,358.3,6959,2)
 ;;=^335278
 ;;^UTILITY(U,$J,358.3,6960,0)
 ;;=787.24^^55^574^24
 ;;^UTILITY(U,$J,358.3,6960,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6960,1,4,0)
 ;;=4^787.24
 ;;^UTILITY(U,$J,358.3,6960,1,5,0)
 ;;=5^Dysphagia,Pharyngoesoph
 ;;^UTILITY(U,$J,358.3,6960,2)
 ;;=^335279
 ;;^UTILITY(U,$J,358.3,6961,0)
 ;;=787.29^^55^574^20
 ;;^UTILITY(U,$J,358.3,6961,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6961,1,4,0)
 ;;=4^787.29
 ;;^UTILITY(U,$J,358.3,6961,1,5,0)
 ;;=5^Dysphagia NEC
 ;;^UTILITY(U,$J,358.3,6961,2)
 ;;=^335280
 ;;^UTILITY(U,$J,358.3,6962,0)
 ;;=584.9^^55^575^2
 ;;^UTILITY(U,$J,358.3,6962,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6962,1,4,0)
 ;;=4^584.9
 ;;^UTILITY(U,$J,358.3,6962,1,5,0)
 ;;=5^Acute Renal Failure
 ;;^UTILITY(U,$J,358.3,6962,2)
 ;;=^67114
 ;;^UTILITY(U,$J,358.3,6963,0)
 ;;=583.9^^55^575^19
 ;;^UTILITY(U,$J,358.3,6963,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6963,1,4,0)
 ;;=4^583.9
 ;;^UTILITY(U,$J,358.3,6963,1,5,0)
 ;;=5^Glomerulonephritis
 ;;^UTILITY(U,$J,358.3,6963,2)
 ;;=^83446
 ;;^UTILITY(U,$J,358.3,6964,0)
 ;;=403.90^^55^575^51
 ;;^UTILITY(U,$J,358.3,6964,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6964,1,4,0)
 ;;=4^403.90
 ;;^UTILITY(U,$J,358.3,6964,1,5,0)
 ;;=5^Renal Insufficiency with Hypertension (CRI and HTN)
 ;;^UTILITY(U,$J,358.3,6964,2)
 ;;=Renal Insufficiency with Hypertension (CRI and HTN)^269609
 ;;^UTILITY(U,$J,358.3,6965,0)
 ;;=593.9^^55^575^9
 ;;^UTILITY(U,$J,358.3,6965,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6965,1,4,0)
 ;;=4^593.9
 ;;^UTILITY(U,$J,358.3,6965,1,5,0)
 ;;=5^Chronic Renal Insufficiency
 ;;^UTILITY(U,$J,358.3,6965,2)
 ;;=Chronic Renal Insufficiency^123849
 ;;^UTILITY(U,$J,358.3,6966,0)
 ;;=581.9^^55^575^37
 ;;^UTILITY(U,$J,358.3,6966,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6966,1,4,0)
 ;;=4^581.9
 ;;^UTILITY(U,$J,358.3,6966,1,5,0)
 ;;=5^Nephrotic Syndrome
 ;;^UTILITY(U,$J,358.3,6966,2)
 ;;=^82357
 ;;^UTILITY(U,$J,358.3,6967,0)
 ;;=753.12^^55^575^43
 ;;^UTILITY(U,$J,358.3,6967,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6967,1,4,0)
 ;;=4^753.12
 ;;^UTILITY(U,$J,358.3,6967,1,5,0)
 ;;=5^Polycystic Kidney Disease
 ;;^UTILITY(U,$J,358.3,6967,2)
 ;;=^67295
 ;;^UTILITY(U,$J,358.3,6968,0)
 ;;=791.0^^55^575^45
 ;;^UTILITY(U,$J,358.3,6968,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6968,1,4,0)
 ;;=4^791.0
 ;;^UTILITY(U,$J,358.3,6968,1,5,0)
 ;;=5^Proteinuria
 ;;^UTILITY(U,$J,358.3,6968,2)
 ;;=Proteinuria^99873
 ;;^UTILITY(U,$J,358.3,6969,0)
 ;;=791.9^^55^575^48
 ;;^UTILITY(U,$J,358.3,6969,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6969,1,4,0)
 ;;=4^791.9
 ;;^UTILITY(U,$J,358.3,6969,1,5,0)
 ;;=5^Pyuria
 ;;^UTILITY(U,$J,358.3,6969,2)
 ;;=^273408
 ;;^UTILITY(U,$J,358.3,6970,0)
 ;;=592.0^^55^575^49
